Frequent epigenetic inactivation of RASSF1A in human bladder carcinoma

Cancer Research

Volumn 61, Issue 18, 2001, Pages 6688-6692

  Lee, M G ^a   Kim, H Y ^a   Byun, D S ^a   Lee, S J ^a   Lee, C H ^a   Kim II, J ^a   Chang, S G ^a   Chi, S G ^a  

^a Kyung Hee University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; BISULFITE; DNA; GENE PRODUCT; ISOPROTEIN; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; RASSF1B PROTEIN; RASSF1C PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BLADDER CARCINOGENESIS; BLADDER CARCINOMA; CANCER CELL CULTURE; CANCER STAGING; CONTROLLED STUDY; CPG ISLAND; DEMETHYLATION; DNA SEQUENCE; GENE INACTIVATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; METHYLATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; PROTEIN EXPRESSION; SEQUENCE ANALYSIS;

ADULT; BASE SEQUENCE; CHROMOSOMES, HUMAN, PAIR 3; CPG ISLANDS; DNA METHYLATION; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GENES, TUMOR SUPPRESSOR; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS; URINARY BLADDER NEOPLASMS;

EID: 0035884193     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints
2. Cloning of a breast cancer homozygous deletion junction narrows the region of search for a 3p21.3 tumor suppressor gene
3. Chromosome 3 allelic losses and microsatellite alterations in transitional cell carcinoma of the urinary bladder
4. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3
5. A novel family of Ras-association domains
6. Identification of Norel as a potential Ras effector
7. Substrate specificities and identification of putative substrates of ATM kinase family members
8. Epigenetic inactivation of RASSF1A in lung and breast cancer and malignant phenotype suppression
9. Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours
10. Hypermethylation of the CpG island of Ras association domain family 1A (RASSF1A), a putative tumor suppressor gene from the 3p21.3 locus, occurs in a large percentage of human breast cancers
11. High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma
12. Ras uses the novel tumor suppressor RASSF1 as an effector to mediate apoptosis
13. Cancer statistics 1997. CA
14. Current management of invasive and metastatic transitional cell carcinoma of the bladder
15. 1 and bladder cancer
16. Genetic alterations in bladder cancer
17. Partial allelotype of carcinoma in situ of the human bladder
18. A molecular genetic model of human bladder cancer pathogenesis
19. Loss of FHIT expression in transitional cell carcinoma of the urinary bladder
20. p53 in prostate: Frequent expressed transition mutations
21. Elevated and biallelic expression of p73 is associated with progression of human bladder cancer
22. Mutational abrogation of the PTEN/MMACl gene in gastrointestinal polyps in patients with Cowden disease
23. Microinjection of the ras oncogene protein into PC12 cells induces morphological differentiation
24. Requirement of NF-κB activation to suppress p53-independent apoptosis induced by oncogenic Ras
25. Mitogenic conversion of transforming growth factor-β1 effect by oncogenic Ha-Ras-induced activation of the mitogen-activated protein kinase signaling pathway in human prostate cancer